FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063820 [Registered on: 08/03/2024] Trial Registered Prospectively
Last Modified On: 22/02/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   A follow up study to assess the effect of interventions from preconception to early childhood on neurodevelopment at 4-6 years  
Scientific Title of Study   Multi-domain interventions from preconception to early childhood and neurodevelopment at 4-6 years  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ravi Prakash Upadhyay  
Designation  Scientist 
Affiliation  Society for Applied Studies 
Address  45 Kalu Sarai

South
DELHI
110016
India 
Phone  01146043751  
Fax  01146043756  
Email  ravi.upadhyay@sas.org.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ravi Prakash Upadhyay  
Designation  Scientist 
Affiliation  Society for Applied Studies 
Address  45 Kalu Sarai

South
DELHI
110016
India 
Phone  01146043751  
Fax  01146043756  
Email  ravi.upadhyay@sas.org.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sunita Taneja 
Designation  Senior Scientist  
Affiliation  Society for Applied Studies 
Address  45 Kalu Sarai

South
DELHI
110016
India 
Phone  01146043751  
Fax  01146043756  
Email  sunita.taneja@sas.org.in  
 
Source of Monetary or Material Support  
Thrasher Research Fund, USA 
 
Primary Sponsor  
Name  Society for Applied Studies  
Address  Society for Applied Studies, 45, Kalu Sarai, Near IIT Delhi, South Delhi-110016, India  
Type of Sponsor  Other [Not for profit research organization] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ravi Prakash Upadhyay  Society for Applied Studies  680, Gali No-5, Nai Basti, Devli Village, Khanpur,New Delhi-110062 South DELHI
South
DELHI 
01146043751
01146043756
ravi.upadhyay@sas.org.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Centre for Health Research and Development, Society for Applied Studies Ethics Review Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Children with 4 to 6 years of completed age  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparator  Receiving standard care through government programs from preconception till child age 24 months 
Intervention  Intervention  Receiving package of health, nutrition, environmental hygiene and psychosocial care from preconception till child age 24 months 
 
Inclusion Criteria  
Age From  4.00 Year(s)
Age To  6.00 Year(s)
Gender  Both 
Details  Children who participated in primary trial(CTRI/2017/06/008908) and whose families consent to participate in the follow up study.  
 
ExclusionCriteria 
Details  Non-consent to participate in the follow up study
- Those with severe illness requiring prolonged hospital admission.
- Those with documented neuro-psychological ailment(s)
- Those with documented visual problems (for eye-tracking assessments)
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Cognition (IQ; intelligence quotient) and higher executive functions   At 4 to 6 years of completed age 
 
Secondary Outcome  
Outcome  TimePoints 
School readiness  At 4 to 6 years of completed age 
Language performance  At 4 to 6 years of completed age 
Psychosocial and emotional behavior  At 4 to 6 years of completed age 
Visual working memory and attention (using eye tracking based assessment)  At 4 to 6 years of completed age 
Quality of stimulation and learning opportunities at home  At 4 to 6 years of completed age 
 
Target Sample Size   Total Sample Size="1052"
Sample Size from India="1052" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Substantial number of under-5 children in low resource settings are documented to be at risk of developmental deficits. Even though it is established that the etiology is multi-factorial, previous studies have largely focused on standalone interventions delivered in specific phases of life i.e., either pregnancy or postnatal or a combination and found small to modest improvements on child neurodevelopment. Effects of additional intervening in the period prior to conception (pre-conception period) are largely unstudied and so is the impact of a package of interventions that address majority of the modifiable risk factors for poor development. Our recent trial (WINGS) (CTRI/2017/06/008908) showed that a package of health, nutrition, psychosocial care, and WaSH interventions encompassing preconception, pregnancy and early childhood periods leads to substantial improvement in neurodevelopmental outcomes at 24 months of age (https://pubmed.ncbi.nlm.nih.gov/38165408/).  

The present study will follow up children, enrolled in the previously conducted WINGS trial, until their pre-school age (4-6 years) and assess their neurodevelopment.

 
Close